Studies on the components of the contact phase system in patients with acute nonlymphoblastic leukemia
Keywords:
Plasmatic prekallikrein, Contact phase, Nonlymphoblastic leukemiaAbstract
The objective of the present study was to evaluate factors of the plasma kallikrein system in patients with acute nonlymphoblastic leukemia (ANLL), and compare the results to a normal control group. A prospective study was performed in the Tertiary Health Care Institution, Hemocentro, Campinas State University, Campinas, São Paulo, Brazil. Thirty-five patients, diagnosed as ANLL between 1988 and 1991, were considered for participation. Eleven patients were not elegible, according to the exclusion criteria: infection/ septicemia, previous treatment or blood transfusion. The study was performed with 24 ANLL patients, average age 34 years (16-69 years), 14 men and 10 women. Nineteen healthy volunteers, workers from the Hematology Center, average age 32 years (21-59 years), 11 men and 8 women, were the control group. Plasmatic prekallikrein, C1-inhibitor, alpha 2-macroglobulin, activated partial thromboplastin time, prothrombin time, factor XII, factor XI, factor V and prealbumin were measured. Plasmatic prekallikrein (p=0.02) and prealbumin (p=0.03) were significantly decreased, and prothrombin time increased (p=0.003) in the patient group when compared to the control. Significant correlation (r=0.49, critical value=0.43, p<0.05) between prekallikrein and prealbumin, and between prothrombin time and factor V (r=0.54, critical value=0.44, p<0.05) was demonstrated in the patient group. No correlation was found between parameters analysed and circulant blast count or leukemia subgroups. Statistical analysis was performed by theWilcoxon test. Correlation between the parameters was also verified. These results suggest activation of the contact system or impaired liver synthesis in patients with ANLL, and could contribute to disease complications.
Downloads
References
Bhoola KD, Figueroa C. KininBioregulation. Pharmacol Rev 1992; 44:1-80.
Chiba Y, Ishihara H, Haned Y, Yoshida Y. Kallikrein system during treatment of hematological malignancies. Adv Exp Med Biol 1979;120A:501-9.
Buzherak NF. Dynamics changes of the kinin system of the blood plasma in patients with acute leucosis. Urach Delo 1982;9:80-83.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnik HR, Sultan C.Proposals for classification of the acute leukemias: French American British (FAB) Cooperative Group. Br J Haematol 1978;33:451-58.
Oliva MLV, Grisolia D, Sampaio MV, Sampaio CAM. Properties of a highly purified human plasma kallikrein. Agents Actions 1982;9:52-55.
Juliano MA, Juliano L.. Synthesis and kinetic parameters of hydrolysis by trypsis of some acyl-arginyl-p-nitroanilides and peptides containing arginyl-p-nitroanilide. Brazilian J Med Biol Res 1985;18:435-445.
Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966;15:45-52.
Proctor PR, Rappaport SI. The partial thromboplastin time with kaolin. Am J Clin Pathol 1961;36:212-19.
Quick AJ. The prothrombin in haemophilia and obstructive jaundice. J Biol Chem 1935;109:73.
Laurieu MJ, Weillard C. Utilization de la cephaline dans le test de coagulation. Rev d'Hematol 1957;12: 199-210.
Quick AJ. The assay and properties of labile factor V. J Clin Pathol 1960;13:457.
Donaldson VH. Serum inhibitor of C1- esterase in health and disease. J Lab Clin Med 1966;68:369-382.
Zuraw BL, Lotz M. Regulation of the hepatic synthesis of C1 inhibitor by the hepatocyte stimulating factors interleukin 6 and interferon gamma. J Biol Chem 1990;265:12664-12670.
Gallimore MJ. Discrepancies between antigen concentrations and functional activities of plasma protease inhibitors. In: Peeters H, eds. Protides of Biological Fluids.London Pergamon Press, 1980.
Keelen AA, Meyer KC, Vogt JM, Edson JR. Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor. Am J Clin Pathol 1987;88:223-228.
Cordova C, Violi F, Alessandri C, Ferro D, Saliola M, Musca A, Balsano F. Prekallikrein and factor VII as prognostic indexes of liver failure. Am J Clin Pathol 1979; 19:579-582.
Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. in: WB Saunders, eds., 1991, chapter 11, 226-243.